Banco Bilbao Vizcaya Argentaria S.A. Trims Position in Henry Schein, Inc. $HSIC

Key Points

• Banco Bilbao Vizcaya Argentaria S.A. reduced its stake in Henry Schein, Inc. by 84.2%, selling 23,669 shares, leaving them with 4,431 shares valued at $303,000.
• Henry Schein reported $1.10 earnings per share for the last quarter, missing estimates of $1.19, while their revenue increased by 3.3% compared to last year.
• Analysts have adjusted their outlook for Henry Schein, with an average target price of $75.58 and a consensus rating of "Hold."

Banco Bilbao Vizcaya Argentaria S.A. lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 84.2% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,431 shares of the company's stock after selling 23,669 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in Henry Schein were worth $303,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of HSIC. Investment Management Corp VA ADV purchased a new position in Henry Schein during the 4th quarter worth $32,000. Rakuten Securities Inc. purchased a new position in shares of Henry Schein during the first quarter valued at $34,000. Whittier Trust Co. increased its stake in shares of Henry Schein by 714.3% during the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after buying an additional 700 shares during the period. UMB Bank n.a. raised its holdings in shares of Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after acquiring an additional 201 shares in the last quarter. Finally, Allworth Financial LP lifted its stake in Henry Schein by 24.5% in the first quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after acquiring an additional 232 shares during the period. Institutional investors own 96.62% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on HSIC shares. Barrington Research reduced their price target on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a report on Wednesday, August 6th. Wall Street Zen raised shares of Henry Schein from a "hold" rating to a "buy" rating in a report on Saturday. Stifel Nicolaus restated a "hold" rating and set a $75.00 target price (down previously from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Evercore ISI raised Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 target price on the stock in a research report on Tuesday. Finally, Leerink Partners set a $75.00 price target on Henry Schein in a research report on Monday, July 14th. Five research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $76.67.

Henry Schein Stock Up 0.8%

Henry Schein stock traded up $0.55 during midday trading on Friday, reaching $69.58. The company's stock had a trading volume of 1,021,767 shares, compared to its average volume of 2,115,911. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The stock has a market capitalization of $8.44 billion, a P/E ratio of 22.45, a PEG ratio of 2.30 and a beta of 0.81. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The stock's 50-day simple moving average is $70.35 and its 200-day simple moving average is $70.04.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The company had revenue of $3.24 billion during the quarter, compared to analysts' expectations of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business's revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, sell-side analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.